Sensorion

Nawal Ouzren, CEO
Montpellier, France
(EPA: ALSEN)
Sensorion is a biotech company, founded in 2009 as a spin-out from INSERM, focused as a “pure player” on developing therapies to treat, prevent, and restore in the field of hearing loss. With our primary strength in the inner ear and neurosciences, we combine world-class scientific excellence and top-tier execution capabilities to deliver first-in-class therapeutics. Sensorion has built an international network of in-house experts, partners, and key opinion leaders. Our leadership has exceptional, solid experience in research, development, management, and business development within the biopharmaceutical industry. Together with our partners, we are committed to build and develop an industry leading pipeline of innovative treatments for hearing loss.
www.sensorion-pharma.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions